Safety-Related Labeling Changes
"Contraception in males and females for 30 days after the last dose. Based on human experience, dasatinib is suspected to cause neural tube defects on the foetus when administered during pregnancy."
Trade Name
Tykodas
Updated Section
4.6 Fertility, pregnancy and lactation
Month
Mar,2023